Skip to main content

Inside the world of cell therapies

While uptake has been limited, cell therapy’s impact in cancer care is growing, and biotech companies have continued to invest in ways to improve it, such as through “off-the-shelf” options or by using different types of immune cells. Explore the current market for cancer cell therapies and what biotechs are working on next.

included in this trendline
  • CAR-T biotech Cargo Therapeutics prices $281M IPO
  • Bristol Myers faces FDA delay on cancer cell therapy decision
  • Gilead expands Arcellx cancer cell therapy deal
Our Trendlines go deep on the biggest trends. These special reports, produced by our team of award-winning journalists, help business leaders understand how their industries are changing.
Davide Savenije Editor-in-Chief at Industry Dive.